Enduro Genetics Raises €12M to Transform the Efficiency of Biomanufacturing at Scale
Danish biotech company Enduro Genetics has secured €12 million in Series A funding for a new patented “synthetic addiction” technology with the potential to slash costs and emissions in biomanufacturing. The biomanufacturing industry — encompassing alternative proteins, industrial enzymes, biodegradable materials, and pharmaceuticals — is plagued by declining productivity at the industrial scale. This happens because large-scale processes cause microorganisms to mutate, creating cell-to-cell variation as cells prioritize their survival …